VK2735
Phase 3Recruiting 0 views this week 0 watching⚡ Active
Interest: 44/100
44
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Weight Loss
Conditions
Weight Loss
Trial Timeline
Jun 23, 2025 → Aug 1, 2027
NCT ID
NCT07104383About VK2735
VK2735 is a phase 3 stage product being developed by Viking Therapeutics for Weight Loss. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07104383. Target conditions include Weight Loss.
What happened to similar drugs?
4 of 20 similar drugs in Weight Loss were approved
Approved (4) Terminated (1) Active (15)
Hype Score Breakdown
Clinical
17
Activity
15
Company
12
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07104383 | Phase 3 | Recruiting |
| NCT07104500 | Phase 3 | Active |
Competing Products
20 competing products in Weight Loss